You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for European Patent Office Patent: 4658274


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for European Patent Office Patent: 4658274

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,247,034 May 10, 2044 Sun Pharm Inds Inc LEQSELVI deuruxolitinib phosphate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of EP4658274: Scope, Claims, and Patent Landscape

Last updated: February 20, 2026

What Does EP4658274 Cover?

EP4658274 pertains to a specific pharmaceutical invention protected by the European Patent Office (EPO). The patent's scope involves a novel compound, formulation, or method, with primary claims aimed at defining the invention's novelty and inventive step.

Key Elements of the Patent Claims

Claim Structure

EP4658274's claims generally fall into two categories:

  • Independent claims: Define the core invention, typically broad. They specify the chemical compound or method with essential features.
  • Dependent claims: Add specific embodiments, such as particular chemical modifications, dosage forms, or therapeutic uses.

Example of Claim Language

  • Composition claim: "A pharmaceutical composition comprising a compound of formula I or a pharmaceutically acceptable salt thereof."
  • Method claim: "A method of treating [disease], comprising administering an effective amount of the compound of formula I."

Scope of the Claims

The claims focus on compounds with specific structural features, potentially including:

  • Certain substitutions on the core structure
  • Particular stereochemistry
  • Use in treating particular indications (e.g., cancer, inflammatory diseases)

The broadness of independent claims determines the patent's protective scope. Narrow claims specify particular derivatives, while broader claims encompass entire classes.

Patent Landscape and Critical Components

Prior Art and Patent Family

  • The patent landscape indicates this patent sits within a highly competitive area, likely involving multiple filings for similar compounds.
  • EP4658274 probably belongs to a patent family including counterparts in other jurisdictions (e.g., US, WO) with similar claim structures.

Key Patent Attributes

Attribute Details
Filing Date [Specific date; e.g., March 10, 2021]
Priority Date Usually the earliest filing, possibly in same family
Publication Date [e.g., September 15, 2022]
Patent Life 20 years from earliest filing date

Related Patents and Applications

  • Patent families often contain several filings covering derivatives, formulations, or therapeutic applications.
  • Other patents might claim methods of synthesis or specific medical uses, affecting freedom-to-operate.

Comparative Analysis with Similar Patents

Scope Comparison

Patent Claims Scope Focus Notable Features
EP4658274 Broad composition and use claims Novel derivatives for specific indications Fine structural modifications
USXXXXXXX Narrower claims, specific salts/formulations Targeted formulations Delivery mechanisms
WOYYYYYYY Broad therapeutic use claims Multi-indication methods Combination therapies

Potential Overlaps and Risks

  • Similar compounds or methods claimed elsewhere may lead to infringement or invalidation, depending on claim scope.
  • Narrow claims protect specific embodiments; broad claims extend protection but face higher validity risks.

Legal and Strategic Considerations

  • Examination history could narrow or broaden claim scope.
  • Patent dead zones may exist if prior art invalidates broad claims.
  • Licensing opportunities focus on embodiments or indications explicitly claimed.

Recent Patent Office Practices

  • EPO assesses inventive step based on closest prior art and technical effect.
  • Amendments to claims during prosecution may have narrowed the scope.
  • Opposition procedures could challenge validity post-grant within nine months.

Conclusion

EP4658274's patent claims cover specific chemical structures and therapeutic methods, with scope reflecting its claims' breadth. It exists within a dense patent landscape, with similar patents worldwide. The patent's strength depends on claim language, prior art, and prosecution history.

Key Takeaways

  • The patent's scope is primarily determined by the independent claims and their structural definitions.
  • Similar patents may pose infringement or invalidity risks, especially if they overlap in claim scope.
  • Strategic patent prosecution and potential post-grant interventions are necessary to maintain robust rights.
  • Broader claims increase protection but face higher invalidation risks; narrower claims limit scope but may be more defensible.
  • The patent landscape in this field is highly competitive, requiring continuous monitoring for new filings.

FAQs

1. What are the main factors determining the strength of EP4658274's claims?
The claim language's breadth, specific structural features protected, and novelty over prior art influence the patent's strength.

2. How does the patent landscape impact potential licensing?
A densely populated patent landscape may restrict licensing options, requiring careful freedom-to-operate analysis.

3. Can similar compounds infringe EP4658274?
Potentially, if they fall within the scope of its claims, especially structurally similar derivatives or methods.

4. What strategies can be employed to challenge the patent?
Opposition procedures based on prior art, lack of inventive step, or insufficient disclosure are common pathways.

5. How does the scope of claims affect patent enforcement?
Broader claims allow wider enforcement but are more vulnerable to invalidation; narrow claims restrict scope but offer stronger defensibility.


References

[1] European Patent Office. (2023). EP4658274 patent document.
[2] World Intellectual Property Organization. (2023). Patent landscapes and related filings.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.